{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T02:14:26Z","timestamp":1782612866736,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006358","name":"Stiftelsen Blanceflor Boncompagni Ludovisi, f\u00f6dd Bildt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FUR2021SM"],"award-info":[{"award-number":["FUR2021SM"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FUR2021SC"],"award-info":[{"award-number":["FUR2021SC"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.nbt.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T16:22:31Z","timestamp":1715271751000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Extracellular Vesicles based STAT3 delivery as innovative therapeutic approach to restore STAT3 signaling deficiency"],"prefix":"10.1016","volume":"82","author":[{"given":"Ilaria","family":"Bettin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Brattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham Ataie","family":"Kachoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Capaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Ashiq","family":"Thalappil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isacco","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Butturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbt.2024.05.001_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nbt.2024.05.001_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nbt.2024.05.001_bib3","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.13442","article-title":"Lipopolysaccharide-activated macrophages regulate the osteogenic differentiation of bone marrow mesenchymal stem cells through exosomes","volume":"10","author":"Song","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.nbt.2024.05.001_bib4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nbt.2024.05.001_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2018.04.037","article-title":"Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics","volume":"279","author":"Cho","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nbt.2024.05.001_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells","volume":"21","author":"Ohno","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.nbt.2024.05.001_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","article-title":"Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery","volume":"192","author":"Pascucci","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nbt.2024.05.001_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nbt.2024.05.001_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118369","article-title":"Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer","volume":"261","author":"Bagheri","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.nbt.2024.05.001_bib10","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/mt.2016.126","article-title":"Exosome-mediated delivery of hydrophobically modified siRNA for Huntingtin mRNA silencing","volume":"24","author":"Didiot","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.nbt.2024.05.001_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J Transl Med"},{"key":"10.1016\/j.nbt.2024.05.001_bib12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.nbt.2024.05.001_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nbt.2024.05.001_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12038-012-9202-x","article-title":"STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6\/STAT3 signalling pathway","volume":"37","author":"He","year":"2012","journal-title":"J Biosci"},{"key":"10.1016\/j.nbt.2024.05.001_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","article-title":"Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome","volume":"125","author":"Woellner","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.nbt.2024.05.001_bib16","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/eji.201141721","article-title":"SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function","volume":"41","author":"Giacomelli","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nbt.2024.05.001_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clim.2011.01.001","article-title":"Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)","volume":"139","author":"Heimall","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nbt.2024.05.001_bib18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10875-014-0011-x","article-title":"Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology","volume":"34","author":"Sundin","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.nbt.2024.05.001_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nbt.2024.05.001_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nbt.2024.05.001_bib21","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbt.2024.05.001_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mi.11.1.4","article-title":"STAT3 signaling: anticancer strategies and challenges","volume":"11","author":"Johnston","year":"2011","journal-title":"Mol Interv"},{"key":"10.1016\/j.nbt.2024.05.001_bib23","first-page":"1","article-title":"IL-6 signal transduction and its physiological roles: the signal orchestration model","volume":"149","author":"Kamimura","year":"2003","journal-title":"Rev Physiol Biochem Pharm"},{"key":"10.1016\/j.nbt.2024.05.001_bib24","article-title":"Targeting the tumor microenvironment: JAK-STAT3 signaling","volume":"2","author":"Bournazou","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.nbt.2024.05.001_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197034","article-title":"Redox regulation of STAT1 and STAT3 signaling","volume":"21","author":"Butturini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nbt.2024.05.001_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4568964","article-title":"Natural sesquiterpene lactones enhance chemosensitivity of tumor cells through redox regulation of STAT3 signaling","volume":"2019","author":"Butturini","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nbt.2024.05.001_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nbt.2024.05.001_bib28","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbt.2024.05.001_bib29","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkac345","article-title":"BeStSel: webserver for secondary structure and fold prediction for protein CD spectroscopy","volume":"50","author":"Micsonai","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nbt.2024.05.001_bib30","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1042\/BCJ20160294","article-title":"Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function","volume":"473","author":"Butturini","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.nbt.2024.05.001_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejpb.2019.11.010","article-title":"Hot EVs \u2013 how temperature affects extracellular vesicles","volume":"146","author":"Schulz","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nbt.2024.05.001_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30786-y","article-title":"Extracellular vesicles protect glucuronidase model enzymes during freeze-drying","volume":"8","author":"Frank","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.nbt.2024.05.001_bib33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.febslet.2013.01.065","article-title":"Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography","volume":"587","author":"Nkansah","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nbt.2024.05.001_bib34","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1021\/cb500407d","article-title":"S-Glutathionylation at Cys328 and Cys542 impairs STAT3 phosphorylation","volume":"9","author":"Butturini","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.nbt.2024.05.001_bib35","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/nbt1096-1246","article-title":"The molecular structure of green fluorescent protein","volume":"14","author":"Yang","year":"1996","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nbt.2024.05.001_bib36","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJM198805193182003","article-title":"Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency","volume":"318","author":"de Pr\u00e9val","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbt.2024.05.001_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202207479","article-title":"Cell-derived vesicles for antibiotic delivery-understanding the challenges of a biogenic carrier system","author":"Heinrich","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.nbt.2024.05.001_bib38","doi-asserted-by":"crossref","first-page":"16701","DOI":"10.1021\/acsomega.0c01582","article-title":"Zeta potential of extracellular vesicles: toward understanding the attributes that determine colloidal stability","volume":"5","author":"Midekessa","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.nbt.2024.05.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101155","article-title":"Extracellular vesicles as personalized medicine","volume":"91","author":"Beetler","year":"2023","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.nbt.2024.05.001_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010122","article-title":"Unlocking the power of exosomes for crossing biological barriers in drug delivery","volume":"13","author":"Elliott","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nbt.2024.05.001_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032917","article-title":"Extracellular vesicles from mesenchymal stem cells: towards novel therapeutic strategies for neurodegenerative diseases","volume":"24","author":"Turano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nbt.2024.05.001_bib42","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nbt.2024.05.001_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.phrs.2016.07.005","article-title":"A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells","volume":"111","author":"Scott","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.nbt.2024.05.001_bib44","doi-asserted-by":"crossref","unstructured":"Toward inflammation-free therapeutics in Alzheimer's disease. Nat Med.\u00a0Vol.\u00a028; 2022. p. 1765\u20136.","DOI":"10.1038\/s41591-022-01972-3"},{"key":"10.1016\/j.nbt.2024.05.001_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nbt.2024.05.001_bib46","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1042\/BCJ20170541","article-title":"Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells","volume":"474","author":"Fagagnini","year":"2017","journal-title":"Biochem J"},{"key":"10.1016\/j.nbt.2024.05.001_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2017.04.036","article-title":"Protein based therapeutic delivery agents: contemporary developments and challenges","volume":"134","author":"Yin","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.nbt.2024.05.001_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pep.2013.05.009","article-title":"Use of baculovirus expression system for generation of virus-like particles: successes and challenges","volume":"90","author":"Liu","year":"2013","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.nbt.2024.05.001_bib49","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extra Vesicles"},{"key":"10.1016\/j.nbt.2024.05.001_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801271","article-title":"TPP1 delivery to lysosomes with extracellular vesicles and their enhanced brain distribution in the animal model of Batten disease","volume":"8","author":"Haney","year":"2019","journal-title":"Adv Health Mater"},{"key":"10.1016\/j.nbt.2024.05.001_bib51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jconrel.2022.07.020","article-title":"Tumor cell-derived extracellular vesicles for breast cancer specific delivery of therapeutic P53","volume":"349","author":"Jiao","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.nbt.2024.05.001_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/srep36338","article-title":"Detailed analysis of protein topology of extracellular vesicles-evidence of unconventional membrane protein orientation","volume":"6","author":"Cvjetkovic","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nbt.2024.05.001_bib53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.addr.2021.04.012","article-title":"A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos","volume":"173","author":"Rankin-Turner","year":"2021","journal-title":"Adv Drug Deliv Rev"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678424000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678424000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T20:39:28Z","timestamp":1718483968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678424000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":53,"alternative-id":["S1871678424000165"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2024.05.001","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular Vesicles based STAT3 delivery as innovative therapeutic approach to restore STAT3 signaling deficiency","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}